Muthukumarasamy Raja/LinkedIn
Aug 13, 2026, 18:31
Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
Muthukumarasamy Raja, Managing Director at GeniusArena Software B.V., shared a post on LinkedIn:
“Plasma is essential in severe bleeding because it replaces lost blood volume and provides clotting factors that help stop hemorrhage.
Yet, traditional plasma was difficult to use in emergencies because it required freezing, lengthy thawing, and strict cold-chain storage.
The FDAโs 2026 approval of EZPLAZ freeze-dried plasma represents a real breakthroughย in emergency care by making plasma rapidly available where and when it is needed most.
Join JobsReach Healthcare, the healthcare industry network, to join the conversation, share your knowledge, and discover healthcare insights and opportunities.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease
-
Sep 3, 2026, 03:51Strengthening Bleeding Disorders Care in New Zealand – WFH
-
Sep 3, 2026, 03:42Nathan Connell: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 03:28Katrina Snow: Learning More About Sickle Cell Disease This September
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden